Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
New therapies for diabesity
Clifford J Bailey
School of Biosciences
Aston Research Centre for Health in Ageing
College of Health and Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New therapies for diabesity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Weight Loss
100%
New Therapies
100%
Diabesity
100%
Type 2 Diabetic Patients
50%
Anti-obesity
50%
Hyperglycemia
50%
Glucagon-like
50%
Insulin Secretion
50%
Single Tablet
50%
Insulinotropic Effects
50%
Once-daily
50%
Hypoglycemia Risk
50%
Minimal Risk
50%
Peroxisome Proliferator-activated Receptor
50%
Dipeptidyl peptidase-4 (DPP-4)
50%
Weight Neutral
50%
Once-weekly
50%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
50%
Loss Risk
50%
Clinical Development
50%
Therapeutic Challenges
50%
Antidiabetic Activity
50%
Receptor Modulators
50%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperglycemia
100%
Tablet
100%
Non Insulin Dependent Diabetes Mellitus
100%
Antidiabetic Agent
100%
Glucagon-Like Peptide-1
100%
Hypoglycemia
100%
Dipeptidyl Peptidase IV Inhibitor
100%
Elimination
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Peroxisome Proliferator Activated Receptor
100%
Medicine and Dentistry
Insulin Release
100%
Glucagon Like Peptide 1
100%
Hypoglycemia
100%
Hyperglycemia
100%
Antidiabetic Agent
100%
Patient with Type 2 Diabetes
100%
Dipeptidyl Peptidase-4 Inhibitor
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Peroxisome Proliferator Activated Receptor
100%